tiprankstipranks
Trending News
More News >
Nihon Kohden Corporation (JP:6849)
:6849
Japanese Market

Nihon Kohden Corporation (6849) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Nihon Kohden Corporation

(6849)

Rating:63Neutral
Price Target:
¥1,803.00
▲(5.44%Upside)
Nihon Kohden Corporation's stock is supported by a strong financial performance with robust revenue growth and financial stability. However, weak technical indicators and modest valuation metrics suggest caution. The bearish momentum and oversold technical indicators are significant risks, slightly balanced by the company's financial strength.

Nihon Kohden Corporation (6849) vs. iShares MSCI Japan ETF (EWJ)

Nihon Kohden Corporation Business Overview & Revenue Model

Company DescriptionNihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyNihon Kohden Corporation generates revenue through the sale of its medical devices and equipment to hospitals, clinics, and other healthcare facilities worldwide. The company's key revenue streams include patient monitoring systems, which are critical for continuous monitoring of patients' vital signs, and diagnostic and therapeutic instruments such as EEG and ECG machines. Additionally, Nihon Kohden offers service contracts and maintenance agreements, ensuring long-term customer relationships and recurring revenue. The company also collaborates with healthcare institutions and research organizations, contributing to steady demand for its advanced medical technologies. Significant factors contributing to its earnings include its strong brand reputation, continuous investment in research and development for innovative products, and a global distribution network that expands its reach into international markets.

Nihon Kohden Corporation Financial Statement Overview

Summary
Nihon Kohden Corporation exhibits a strong financial position with consistent revenue growth and profitability. The company maintains low leverage and solid equity, ensuring financial stability. Cash flow management is effective, though maintaining growth in operating cash flow is crucial.
Income Statement
82
Very Positive
Nihon Kohden Corporation demonstrated robust growth with a revenue increase of 8.5% from 2023 to TTM (Trailing-Twelve-Months). Gross profit margin stands at an impressive 51.1%, and the net profit margin is a healthy 7.7%. Despite a slight dip in EBIT margin to 8.9% from 10.2%, the company's steady EBITDA margin of 10.7% underscores its operational efficiency. Overall, the income statement reflects strong profitability and growth prospects.
Balance Sheet
78
Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.15, indicating prudent financial leverage. The equity ratio is robust at 72.1%, showcasing a solid capital structure. Return on equity (ROE) is at 9.7%, showing effective use of shareholders' equity. However, a slight decrease in stockholders' equity suggests a need for careful monitoring. Overall, the balance sheet indicates financial stability and low risk.
Cash Flow
75
Positive
Nihon Kohden's cash flow reveals a decrease in operating cash flow from 2023, yet it remains positive at 14.1 billion yen for TTM. Free cash flow is strong at 9.1 billion yen, although it shows a decline from previous years. The free cash flow to net income ratio is 0.53, indicating a solid conversion of earnings to cash. The cash flow statement reflects healthy liquidity but highlights the importance of sustaining operating cash flow growth.
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
224.29B221.99B206.60B205.13B199.73B185.01B
Gross Profit
114.71B111.35B105.93B109.09B102.23B89.33B
EBIT
20.01B19.59B21.12B30.99B27.09B15.50B
EBITDA
24.03B33.25B24.91B34.48B31.64B19.25B
Net Income Common Stockholders
17.24B17.03B17.11B23.43B18.24B9.85B
Balance SheetCash, Cash Equivalents and Short-Term Investments
38.52B50.43B44.46B60.92B44.61B35.97B
Total Assets
246.29B233.23B216.73B210.20B193.03B167.79B
Total Debt
25.96B654.00M441.00M359.00M404.00M401.00M
Net Debt
-3.06B-35.48B-33.02B-28.57B-30.20B-20.57B
Total Liabilities
68.59B52.15B49.13B53.82B54.05B46.01B
Stockholders Equity
177.69B181.08B167.60B156.38B138.98B121.77B
Cash FlowFree Cash Flow
9.11B10.82B-10.77B22.77B10.56B5.63B
Operating Cash Flow
14.13B15.61B-2.51B25.70B13.95B9.22B
Investing Cash Flow
-25.22B-5.21B-7.65B-4.30B-2.95B-4.61B
Financing Cash Flow
3.58B-6.97B-7.49B-7.30B-3.01B-3.05B

Nihon Kohden Corporation Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1710.00
Price Trends
50DMA
1752.96
Negative
100DMA
1952.02
Negative
200DMA
2019.83
Negative
Market Momentum
MACD
-16.59
Negative
RSI
47.37
Neutral
STOCH
60.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6849, the sentiment is Negative. The current price of 1710 is below the 20-day moving average (MA) of 1719.60, below the 50-day MA of 1752.96, and below the 200-day MA of 2019.83, indicating a bearish trend. The MACD of -16.59 indicates Negative momentum. The RSI at 47.37 is Neutral, neither overbought nor oversold. The STOCH value of 60.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6849.

Nihon Kohden Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
¥285.47B20.15
1.87%1.55%-15.62%
54
Neutral
$5.38B3.31-45.11%3.29%16.82%0.04%
DE2GY
€700.44M10.637.51%4.80%
78
Outperform
¥8.68B8.45
4.19%4.59%1130.01%
78
Outperform
¥30.42B10.63
3.00%8.36%7.74%
74
Outperform
¥15.73B12.72
3.68%5.92%8.59%
66
Neutral
¥65.05B31.39
2.65%1.22%-8.83%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6849
Nihon Kohden Corporation
1,716.00
-559.38
-24.58%
DE:2GY
PHC Holdings Corp.
5.40
-1.09
-16.80%
JP:4549
Eiken Chemical Co., Ltd.
2,103.00
134.56
6.84%
JP:5187
Create Medic Co., Ltd.
954.00
5.99
0.63%
JP:6678
Techno Medica Co., Ltd.
1,860.00
153.88
9.02%
JP:6823
Rion Co., Ltd.
2,447.00
-332.63
-11.97%

Nihon Kohden Corporation Corporate Events

Nihon Kohden Announces Change in Largest Shareholder
May 27, 2025

Nihon Kohden Corporation announced a change in its largest shareholder, with Sprucegrove Investment Management Ltd. now holding a reduced share of 9.76% as of May 16, 2025, down from 10.88% previously. This change, confirmed by a Report of Possession of Large Volume submitted to the Kanto Local Finance Bureau, may influence the company’s shareholder dynamics but does not immediately affect its operational outlook.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

Nihon Kohden Corrects Financial Highlights for FY2025
May 20, 2025

Nihon Kohden Corporation announced a correction to its Consolidated Financial Highlights for the fiscal year ended March 31, 2025, due to errors discovered post-announcement. This correction pertains to the Financial Condition section, which may impact stakeholders’ understanding of the company’s financial health and future strategy.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

Nihon Kohden Corrects Financial Results for FY2025
May 20, 2025

Nihon Kohden Corporation announced corrections to its consolidated financial results for the fiscal year ended March 31, 2025, due to errors in the calculation of income taxes and tax effects. The corrections resulted in adjustments to the Consolidated Balance Sheets and Non-Consolidated Balance Sheets, increasing both total assets and liabilities without affecting net assets. This announcement highlights the company’s commitment to transparency and accuracy in financial reporting, which is crucial for maintaining stakeholder trust and ensuring compliance with financial regulations.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

Nihon Kohden Reports FY2024 Financial Results and Announces Stock Split
May 13, 2025

Nihon Kohden Corporation reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in net sales by 1.5% compared to the previous year, despite a significant decrease in net income by 34.1%. The company also announced a stock split effective July 1, 2024, and included three new subsidiaries in its consolidation scope, which may impact its market positioning and stakeholder interests.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

Nihon Kohden Introduces Employee Stock Ownership Plan
May 13, 2025

Nihon Kohden Corporation has announced the introduction of an Employee Stock Ownership Plan as an incentive for its employees and some subsidiaries, aiming to enhance motivation and contribute to long-term business performance. The plan involves the disposal of treasury stock through a third-party allotment, with 930,000 shares allocated to Custody Bank of Japan, Ltd., reflecting a minor impact on the secondary market.

The most recent analyst rating on (JP:6849) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.

Nihon Kohden Announces Leadership Changes
Apr 23, 2025

Nihon Kohden Corporation announced a significant change in its leadership, with the retirement of Representative Director Takashi Tamura due to health reasons, effective June 26, 2025. The company also introduced new director candidates, including Kazuhiro Kato and Mamoru Morita, as part of its strategic leadership restructuring, which could impact its corporate governance and strategic direction.

Nihon Kohden Completes Share Buyback Program
Mar 25, 2025

Nihon Kohden Corporation announced the completion of its share buyback program, acquiring a total of 493,200 common shares for approximately 1.05 billion yen through market purchases on the Tokyo Stock Exchange. This acquisition finalizes the company’s plan, initially resolved by the Board of Directors in May 2024, to buy back up to 6 million shares, aiming to enhance shareholder value and optimize capital structure.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.